A one-minute look at managed care news during the week of April 13, 2015, including a the official repeal of the sustainable growth rate formula and a look at the rising cost of generic drugs.
Weeks after the House passed legislation that would repeal the sustainable growth rate (SGR) formula that determines Medicare payments, the Senate overwhelmingly passed the legislation as well. Two days later President Barack Obama signed the bill into law.
The Office of the Inspector General of HHS will review the impact of generic drug price increases on the Medicaid drug rebate program. Last year, The American Journal of Managed Care (AJMC)'s co-editor-in-chief, A. Mark Fendrick, MD, wrote about the costs of non-preferred generic drug pricing tiers.
Finally, there's still time to join AJMC in San Diego, April 30-May 1, for the third annual ACO and Emerging Healthcare Delivery Coalition. Learn more and register here.
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Research Shows Prior Authorization Denials Delay Critical Immunology Care
May 10th 2024Results featured at the Academy of Managed Care Pharmacy 2024 annual meeting revealed a pattern of prior authorization rejections that could delay necessary therapeutic treatments for various patient groups.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen